16 Sep 2013 07:00
For immediate release | 16 September 2013 |
Â
Â
Â
Futura Medical plc
("Futura" or the "Company")
Â
Appointment of Nominated Adviser and Broker
Â
Â
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce the appointment with immediate effect of Cenkos Securities plc as the Company's nominated adviser and broker.
Â
Â
Â
Â
For any further information please contact:
Â
Futura Medical plc | |
James Barder, Chief Executive  | Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
  | |
Cenkos Securities plc | |
Bobbie Hilliam | Tel:+44 (0)20 7397 8900 |
  | |
For media enquiries please contact: | |
Buchanan | |
Mark Court / Fiona Henson / Sophie Cowles www.buchanan.uk.com  | Tel: +44 (0)20 7466 5000 |
Â
Â
Notes to Editors
Â
Futura Medical plc
Â
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Â
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
Â